BMY MEXC RealStocks
Own real BMY shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 20:37:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Bristol-Myers Squibb Co. (BMY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $62.76, with a market capitalization of $128.37B and a P/E ratio of 13.85. Over the past 52 weeks, its price has ranged from $45.27 to $68.64. This page covers its latest market performance, valuation, price trends and company information.
$128.37B | |
$63.80 | |
$63.83 | |
$62.46 | |
$62.91 | |
4.67M | |
10.92M | |
13.85 | |
$68.64 | |
$45.27 | |
3.96% | |
12-31 |
Bristol-Myers Squibb Co. (BMY) is currently trading at $62.76 as of 2026-11-12 20:21:00, down 0.29% ($0.18) from the previous close of $62.91
During today's regular trading session, BMY has traded between $62.46 and $63.83, with a trading volume of 4.67M shares. The current price is near the lower end of today's range.
Over the past seven days, Bristol-Myers Squibb Co. (BMY) moved from $61.71 to $62.76, representing a gain of 1.70% ($1.05).
The stock traded between $61.30 and $65.54 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 9.28 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 74.8%
BMY is currently trading at $62.76, placing it 74.8% of the way from its 52-week low of $45.27 to its 52-week high of $68.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 32,500 |
| CEO | Christopher S. Boerner |
| Founded | 1887 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Bristol-Myers Squibb Co.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Bristol-Myers Squibb Co. (BMY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to BMY, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between BMY shares and USD.
BMY Shares to USD
1.00 BMY shares = 62.76 USD
Calculations are estimates based on the latest available price and are for reference only.